N David Gill

Affiliations

  • Director at Evolus Inc. (EOLS), 2025-03-11
  • Director at Y-Mabs Therapeutics Inc. (YMAB), 2024-06-14
  • Director at Strongbridge Biopharma Plc (SBBP), 2021-10-06
  • at Strata Skin Sciences Inc. (SSKN), 2019-11-26
  • Director at Melinta Therapeutics Inc. W (MLNT), 2019-06-12
  • Director at Histogenics Corp (HSGX), 2018-06-19
  • President And Cfo at Endochoice Holdings Inc. (GI), 2016-11-23
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SBBP $2.13 8,000 $17,040.00 74,896 2020-09-24 Filing
EOLS $13.65 2,000 $27,300.00 5,000 2019-06-13 Filing
EOLS $12.77 3,000 $38,300.10 3,000 2018-12-14 Filing
MLNT $6.09 5,000 $30,450.00 6,000 2018-05-25 Filing
HSGX $1.81 3,000 $5,439.00 14,000 2017-08-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EOLS $12.60 6,718 $84,653.52 33,964 2024-05-14 Filing
EOLS $12.72 3,643 $46,356.08 40,682 2024-05-13 Filing
EOLS $13.62 5,000 $68,080.00 29,568 2022-05-16 Filing
EOLS $13.10 5,313 $69,584.36 34,568 2022-05-13 Filing
YMAB $46.52 2,000 $93,045.20 0 2021-01-19 Filing